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ABSTRACT
Bacterial translocation is deﬁned as the passage of live bacteria from the gut lumen to distant sites.
Gut commensal bacteria translocation has been attributed to ‘leakiness’, or ‘barrier breach’ of the
intestinal epithelium, allowing live bacteria to cross an inappropriately permeable barrier and
disseminate to distant sites. Alternatively, studies suggest dendritic cells directly capture luminal
commensal bacteria and transport them to distant sites in the steady-state by extending dendrites
between epithelial cells into the lumen. Recently we identiﬁed translocation of commensal gut
bacteria following antibiotics was associated with the formation of goblet cell associated antigen
passages (GAPs) in the colon and dependent upon goblet cells (GCs). The translocation of native
gut commensal bacteria resulted in low-level inﬂammatory responses and potentiated mucosal
damage in response to concurrent epithelial injury. Here we extend these observations and
demonstrate properties of colonic GAPs and observations supporting their priority in the




At the time of their introduction, antibiotics were
viewed as miracle drugs, allowing patients to survive
diseases that were previously thought to be untreat-
able. However widespread exposure to antibiotics is
now associated with multiple immune mediated disor-
ders, which in turn have been correlated with antibi-
otic induced alterations of the gut microbiota.1-6 Yet
how dysbiosis of the gut microbiota confers a risk for
inﬂammatory immune responses at local and distant
sites is poorly understood. We identiﬁed an unappre-
ciated effect of antibiotics inducing the translocation
of commensal gut bacteria and inducing inﬂammatory
responses by allowing colonic goblet cells (GCs) to
form goblet cell associated antigen passages (GAPs)
and deliver luminal substances, including live bacteria,
to antigen presenting cells (APCs) in the colon lamina
propria (LP).7
The gut LP contains a spectrum of myeloid
APCs, including CD11bC CD103- CX3CR1C APCs
with features of macrophages and CD11bC
CD103C CX3CR1- APCs with features of dendritic
cells,8-11 which will be referred to collectively as
mononuclear phagocytes (MNPs). GAPs were
observed to be a major pathway delivering luminal
antigens to LP-MNPs in the steady-state, as dele-
tion of GCs or manipulation of GAPs abrogates
antigen delivery to LP-MNPs as evidenced by their
inability to induce T cell responses to luminal anti-
gen.12,13 GAPs form in response to acetylcholine
(ACh) acting upon the muscarinic ACh receptor 4
(mAChR4) expressed by GCs.13 The formation of
GAPs occurs in the steady-state in the small intes-
tine (SI), but conversely GAP formation is inhib-
ited in the colon of SPF housed mice by GC
intrinsic Myd88 dependent sensing of the micro-
biota.13 Myd88 dependent microbial sensing in
GCs trans-activates the epidermal growth factor
receptor (EGFR) activating p42/p44 mitogen acti-
vated protein kinase (MAPK), which suppresses
responses to ACh via the mAChR413. Consistent
with this we observed that treatment with oral anti-
biotics induced the formation of colonic GAPs, and
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this was followed by spontaneous translocation of
native colonic commensal bacteria to the colon
draining mesenteric lymph node (MLN) as the gut
microbiota was being restored following antibiotic
cessation.7
This effect of antibiotics occurs following a single
dose of antibiotics, during continuous sub-therapeutic
antibiotic therapy, or during a period of time after ces-
sation of therapeutic antibiotic therapy in which
colonic GAPs are formed due to the loss of suppres-
sive effects of the intact gut microbiota on GAP for-
mation, but when the gut bacterial load is sufﬁcient to
translocate.7 The translocation of commensal bacteria
after antibiotics or in mice with reduced or absent
microbiota, such as germfree mice, is a well-docu-
mented phenomena,14-17 correlating to our ﬁnding
that the presence of the normal gut ﬂora inhibits
colonic GAPs and prevents bacteria translocation.
Further we observed that most but not all antibiotics
evaluated induced colonic GAP formation and bacte-
rial translocation despite equivalent alterations in the
overall colonic bacterial load,7 suggesting that some
bacteria may have an enhanced capacity to inhibit
GAPs and subsequent translocation and giving hope
that antibiotic therapies could be tailored to mitigate
this untoward effect. However the considerable ques-
tions as to which bacterial species inhibit colonic GAP
formation and translocation in a given individual’s
gut microbiota and how antibiotics could be tailored
for an individual’s gut microbiota to avoid transloca-
tion will require signiﬁcant more work to be answered.
Regional location and properties of colonic GAPs
and translocation of commensal gut bacteria in the
presence and absence of antibiotic treatment
Translocation of gut commensal bacteria to the MLN
draining the SI was not observed in the absence of
antibiotic therapy, and was rare in the presence of
antibiotic therapy,7 suggesting that SI GAPs, which
are present independent of antibiotic treatment do not
have the property of commensal bacterial transloca-
tion. The small amount of bacteria seen in a few
instances following antibiotic therapy in the MLN
draining the SI may have translocated via colonic
GAPs as the lymph drainage patterns between the SI
and portions of colon can overlap. We expanded these
observations by evaluating the presence of GAPs in
various regions of the colon using in vivo 2-photon
(2P) imaging approaches and by imaging ﬁxed tissue
sections following the administration of luminal ﬂuo-
rescent dextran.12,13 The latter approach allows evalu-
ation of GAP density in regions of the GI tract that
are difﬁcult to image using the in vivo approach due
to the abundant luminal contents, such as in the
cecum, or areas that are not easily accessible for in
vivo imaging due to anatomy, such as the sigmoid
colon. Consistent with our prior observations, we
found that GAPs were rare, or nearly absent, in the
cecum, ascending colon, and transverse colon in the
steady-state (Fig. 1A, B, D, and E). However in con-
trast to the proximal colonic regions, GAPs were
observed in the crypts of the descending colon and
sigmoid colon in the absence of antibiotic treatment
(Fig. 1A, B, D, and E). The presence of GAPs in the
distal colon and their absence in the proximal colon in
the steady-state, may provide the basis for the ability
of SPF housed mice to be tolerized to high doses of
antigen in the colonic lumen in the iliac and caudal
lymph nodes, which drain the distal colon segments,
but not in the MLNs draining the proximal colon in
the steady-state.18
The colonic lymphatics drain into 3 anatomically
distinct lymph node (LN) populations19,20 (Fig. 1C).
The cecum and ascending colon lymphatics drain into
the colonic MLN, the transverse colon lymphatics
drain to a duodendopancreatic LN found behind the
colon, referred to here as the colic LN, and the
descending and sigmoid colon drain into the caudal
LN and iliac LNs19-21 (Fig. 1C). This lymphatic drain-
age pattern allows evaluation of live bacteria in the
various LN populations to inform where bacteria have
traversed the colonic epithelium21,22 Despite the pres-
ence of colonic GAPs in the descending and sigmoid
colon, we did not observe live commensal bacteria in
the caudal or iliac LNs at steady-state (Fig. 1F). The
presence of GAPs and the absence of bacterial translo-
cation to the LN draining the distal colon may be due
to the more dense and less penetrable mucus layer in
the distal colon,23 which would reduce the exposure of
GCs to bacterial products and allow GAPs to form
while at the same time preventing luminal bacteria
from accessing the GAPs.
Following antibiotic therapy, which disrupts the
luminal commensal bacteria, we observed a signiﬁcant
increase in GAP formation in all segments of the colon
with the exception of the sigmoid colon, which showed
a trend towards an increase (Fig. 1A, B, D, and E).
GUT MICROBES 401
Imaging of ﬁxed tissues revealed that GAPs forming in
the sigmoid colon in the steady-state and those forming
after antibiotic therapy appeared structurally similar
(Fig. 1B). The level of GAP induction following
antibiotic treatment correlated with the level of translo-
cation of live commensal bacteria to the LNs, with the
exception of the LN draining the distal colon, which did
not contain bacteria in the steady-state or following
Figure 1. Regional location of colonic GAPs and translocation of commensal gut bacteria in the presence and absence of antibiotic treat-
ment. (A) Mice were given regular water (top row; Con) or Ampicillin (1 g/L), metronidazole (1 g/L), neomycin(1 g/L), and vancomycin
(500 mg/L) (second row; ABX) in drinking water for 1 week, and then placed on regular drinking water for 3 days.7 For two-photon (2P)
imaging, mice were injected intraluminally with 2 mg 10 kDa rhodamine-labeled dextran and 1 mg DAPI. 20 minutes later mice were
imaged as described previously.7,12,13 White arrow denotes GAPs; GCs ﬁlled with dextran. (B) After 30 minutes of ﬁxation in 10% buff-
ered formalin, colonic tissue with intraluminal dextran was sectioned and imaged by routine ﬂuorescent microscopy to visualize struc-
ture of GAPs. White arrows denote GAPs. (C) Schematic summarizing the lymphatic draining pattern of the intestine. (D-E) Graphical
representation of GAPs per crypt in the regions of the colon in control mice or mice following antibiotic treatment by D) 2P imaging E)
or ﬂuorescent microscopy (FM) of ﬁxed tissue sections. Color of the bars in graphs correlates with the segment of colon draining to the
corresponding LN in panel C and F. (F) Graphical representation of CFUs per LN after plating LN homogenates7 on LB agar overnight in
control mice or mice following antibiotic treatment. n D 4 mice per group, Asc colon D ascending colon, Trans colon D transverse
colon, Des colonD descending colon, Sig colonD sigmoid colon, NDD not detected, ns D not signiﬁcant, statistical analysis performed
using a Student’s t-test,  D p < 0.05.
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antibiotic treatment (Fig. 1D-F), further supporting that
a more dense mucus layer may protect the caudal LN
from translocation of bacteria through the distal colon.
Colonic GAPs in the proximal colon that were induced
by antibiotic therapy transported a variety of luminal
substances including proteins, lectins, and sugars
(Fig. 2A, C); however unlike their SI counterparts,
colonic GAPs did not transport LPS (Fig. 2B, C) as GC
sensing of luminal LPS rapidly shut off GAPs in the
colon, but not in the SI.13
CX3CR1C LP-MNPs interact with GAPs in
the SI and colon
CX3CR1- (CD103C) LP-MNPs were observed to
interact with SI GAPs more often that CX3CR1C
(CD103-) LP-MNPs in the steady-state, however
luminal antigen was acquired in a manner capable of
inducing T cell responses by both SI LP-MNP sub-
types when GAPs were robustly induced by exogenous
administration of the ACh analog carbamylcholine.12
This suggests that CX3CR1C LP-MNPs also acquire
antigen from GAPs, but consistent with other reports
are less efﬁcient at stimulating T cell responses.8 Fur-
thermore CX3CR1C LP-MNPs interact with and
acquire luminal antigen from colonic GAPs,7,13 and
are necessary for the dissemination of translocated
bacteria to the MLN,7,24 suggesting that CX3CR1C
LP-MNPs interact with colonic GAPs to acquire lumi-
nal commensal bacteria following antibiotic therapy.
We therefore evaluated if CX3CR1C LP-MNPs associ-
ated with GAPs in the various regions of the intestine
in the steady-state and following antibiotic therapy.
We observed CX3CR1C LP-MNPs making multiple
contacts with GAPs in the SI, spanning several z-
stacks (Fig. 3A) and forming contacts with 20% of the
GAPs during in vivo imaging (Fig. 3C). We found that
CX3CR1C LP-MNPs were removed from the epithe-
lium in the ascending and transverse colon in the
steady-state (Fig. 3D), but associated with the epithe-
lium and were found interacting with GAPs, wrapping
dendrites around GAPs, and forming contacts with
>60% of GAPs in the ascending and transverse colon
following antibiotic therapy (Fig. 3D, E, F). CX3CR1C
LP-MNPs made contacts with 40% of the GAPs in the
distal colon in the steady-state, but did not
Figure 2. Colonic GAPs acquire a variety of substances following antibiotic treatment. (A) Representative 2-photon images of transverse
colonic GAPs after antibiotic treatment ﬁlled with (left) luminal alexa-647 labeled ovalbumin (Ova), (middle) luminal alexa-647 labeled
bovine serum albumin (BSA), or (right) luminal ﬂuorescein isothiocyanate (FITC) labeled peanut agglutinin (PNA), white arrows denote
GAPs. (B) Representative 2-photon images of (left) transverse colon or (right) distal ileum showing colonic GCs do not, but SI GC do ﬁll
with FITC labeled lipopolysaccharide (LPS), white arrows denote GAPs. (C) Graphical representation of GAPs per colonic crypt or SI villus
ﬁlled with various proteins or lectins as assessed by 2P imaging. n D 3 mice per group, statistical analysis was performed using a t-test,
 D p < 0.05.
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Figure 3. CX3CR1C LP-MNPs interact with GAPs and acquire luminal antigen in the colon following antibiotic treatment. (A) Serial 5mm z-
stacks of a villus from a CX3CR1
GFP/WT reporter mouse41 starting 10mm from the lumen acquired by in vivo 2P imaging after intraluminal
injection with 10 kDa ﬂuorescent dextran and DAPI; white arrows denotes CX3CR1C cell contacting a GAP. (B) 2P images of a villus from a
CX3CR1
GFP/WT mouse after intraluminal injection with dextran and DAPI, inset shows higher magniﬁcation of CX3CR1C cell contacting a
GAP. (C) Graphical representation of the ratio of GAPs being contacted by a CX3CR1C cell to the number of total GAPs in the SI in control
mice or after washing the lumen with 5 ml of 37C PBS to remove the luminal contents and mucus, as described in imaging approaches
used by others.27-29,33,34 (D) 2P images of the colon of a control CX3CR1
GFP/WT mouse (Con) or following antibiotic treatment (ABX) after
intraluminal injection of dextran and DAPI, white arrows denotes CX3CR1C cell contact with a GAP, white dotted line indicates lumen. (E)
Confocal microscopy image of CX3CR1
GFP/WT mouse following antibiotic treatment showing CX3CR1C cell contacting a dextran ﬁlled GAP
(white arrow) in the transverse colon; white dotted line indicates lumen. (F) Graphical representation of the ratio of GAPs being contacted
by a CX3CR1C cell to the number of total GAPs in the colon of control mice or after antibiotic treatment. (G) Control mice (Con) or antibi-
otic treated mice (ABX) were injected intraluminally with PBS or 10 mg ovalbumin (Ova); 2 hours later LP-MNPs were isolated from the
colon, sorted as CD45CCD11cCMHCIICCD103C cells or CD45CCD11cCMHCIICCD103¡ cells, and cultured with sorted
CD45CCD62LCCD3CCD48CVa2C Ova speciﬁc splenocytes from OTI T cell receptor transgenic mice42 at a 1:10 ratio. Graphical representation
of fold increase OTI T cells 3 d after co-culture with LP-MNPs. n D 3 mice per group, statistical analysis was performed using a Student’s t-
test,  D p < 0.05, ns D not signiﬁcant, ND D not detected.
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signiﬁcantly increase after antibiotic treatment
(Fig. 3D, F). Furthermore we found that following
antibiotic treatment, CD103C LP-MNPs and CD103-
LP-MNP, which are CX3CR1C,7,11 acquired luminal
ovalbumin in a manner able to induce na€ıve T cell
proliferation (Fig. 3G), further supporting that
CX3CR1C LP-MNPs can acquire luminal substances,
including soluble antigens and bacteria from GAPs.7
Priority of GCs/GAPs in the translocation of native
commensal bacteria following antibiotic therapy
Translocation of non-pathogenic luminal bacteria
after antibiotic treatment is not associated with barrier
breach or changes in tight junction permeability,25
making alterations in barrier function an unlikely
mediator of this event. Villous M-cells could translo-
cate luminal bacteria to the underlying LP without
altering barrier function, however M-cells have not
been observed on the non-follicle bearing epithelium
of the colon26 where the translocation of commensal
bacteria occurs following antibiotics,7,15 making them
unlikely participants in this process. The discovery of
the ability of LP-MNPs to extend trans-epithelial den-
drites (TEDs) to sample the lumen provided an expla-
nation for how bacterial translocation might occur in
the absence of epithelial damage or loss of barrier
function. However several inconsistencies, includ-
ing the density and regional location of TED exten-
sion27-32 and the ability of microbial stimuli to induce
TED extension while suppressing bacterial transloca-
tion,7,24,28 suggest that TEDs may not be the mecha-
nism for translocation of luminal commensal bacteria
following antibiotic therapy. We evaluated the ability
of CX3CR1C colonic LP-MNPs to extend TEDs in the
presence and absence of antibiotic therapy. Consistent
with other reports,30 we did not observe TED exten-
sion by CX3CR1C colonic LP-MNPs in the steady-
state or following antibiotic treatment (Fig. 4A). While
CX3CR1C colonic LP-MNPs increased contact with
the colonic epithelium and GAPs after antibiotic treat-
ment, CX3CR1C dendrites were never seen crossing
the epithelial barrier to contact the lumen. Thus
colonic TED formation was unlikely to mediate trans-
location of colonic luminal bacteria.
Furthermore we found the formation of TEDs to
be an exceedingly rare even in the SI of untreated
mice (Fig. 4C); we observed only 2 TEDs while evalu-
ating over 500 entire villi, from tip to base (Fig. 4E).
We noted that studies of LP-MNP TED extension in
the SI, rinsed the lumen of the intestine with PBS to
remove the luminal contents and mucus,27-29,33,34 a
practice we did not use as mucus is a vital component
of the barrier protecting the epithelium from the lumi-
nal contents.23,35 When we removed the luminal con-
tents and mucus by rinsing with PBS, TED extension
by LP-MNPs became apparent on the tip and in the
middle of SI villi (Fig. 4D) at a rate of approximately
1.5 TEDs per villus in the ileum or »0.7 TEDs per
villus combining all regions of the SI when examining
over 300 villi (Fig. 4E), which is highly consistent with
prior studies reporting the density and regional loca-
tion of TED extension.27,28 Often TEDs could be seen
near or extending past GAPs (Fig. 4D right top, right
bottom) but TEDs also formed independently of
GAPs (Fig. 4D left bottom), indicating that TED for-
mation was not dependent upon GAPs. Even after
stringent washing, TEDs failed to form in the colon
(Fig. 4B), corroborating the lack of TED extension in
the colon in other models.30,31
Evaluating the density of TED extension and GAPs
simultaneously within the same mouse we observed
that GAPs were signiﬁcantly more common than the
extension of TEDs in the SI in the steady-state (»1000
fold) and in the colon following antibiotic treatment
(»1000 fold; Fig. 4E). Additionally, removal of the
protective mucus barrier from the epithelium before
imaging increased the contacts CX3CR1C LP-MNPs
made with SI GAPs to 60% of the GAPs (Fig. 3C), sug-
gesting CX3CR1C SI LP-MNPs increase both TED
extension and sampling from GAPs when the mucus
barrier is disturbed. Where examined, all studies eval-
uating the extension of TEDs by LP-MNPs agree that
they are induced by enteric pathogens.27-29,34 Our
observation that TED extension by LP-MNPs becomes
more common after removal of the mucus layer and
observations that epithelial Myd88 signals induce SI
LP-MNPs to extend TEDs,28 together suggest that
TED extension occurs in response to epithelial stress
signals. Conversely GAPs are inhibited by epithelial
sensing of the microbiota in the colon.13 While SI
GAPs were not inhibited by the commensal micro-
biota, SI GCs expressed TLRs, MyD88, and the EGFR,
and activation of this pathway by EGFR ligands can
inhibit GAPS in the SI. The ability of the commensal
microbiota to inhibit GAPs in the colon, but not in
the SI, could be due to lower levels of expression of
TLRs and/or higher expression of negative regulators
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of TLR signaling in SI GCs when compared with colon
GCs.13 However the preservation of this pathway in SI
GCs raises the possibility that SI GAPs could be inhib-
ited in some situations, such as enteric infection.
These observations suggest that GAPs and TEDs may
play opposite roles as routes for the immune system’s
exposure to luminal substances, with GAPs having a
higher priority in homeostatic responses and TED
extension by SI LP-MNPs having a higher priority
during stress and infection.
Figure 4. GAPs are signiﬁcantly more common than the extension of trans-epithelial dendrites (TEDs) by CX3CR1C LP-MNPs in the steady-
state or following antibiotic treatment. 2P images of the transverse colon (A) without PBS wash or (B) with PBS wash to remove luminal
contents and mucus from CX3CR1
GFP/WT mice given drinking water alone (Con) or antibiotic treatment (ABX) and intraluminal injection
of dextran and DAPI; green arrows denote CX3CR1C LP-MNPs, white arrows denote GAPs. (C) 2P images of the tip and mid small intesti-
nal villus of an untreated CX3CR1
GFP/WT mouse after intraluminal injection of dextran and DAPI, white arrows denote GAPs. (D) 2P images
of the tip and mid small intestinal villus of an untreated CX3CR1
GFP/WT mouse after intraluminal injection of dextran and DAPI following
PBS rinsing, white arrows denote GAPs, yellow arrow denotes a TED. (E) Graphical representation of the number of TEDs, counted as
CX3CR1
GFP/WT dendrites extending into the lumen, as delineated by the DAPIC epithelial border, per villus or ascending colonic crypt
and the number of GAPs per villus or ascending colonic crypt to show frequency of TEDs compared the frequency of GAPs. n D 3 mice
per group in panel E, statistical analysis was performed using a Student’s t-test,  D p < 0.05, ND D not detected.
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Dissemination of luminal bacteria to the MLN
requires sphingosine 1 phosphate receptor 1 (S1PR1)
The gut commensalmicrobiota restricts translocation and
dissemination of commensal bacteria.7,24 Translocation of
bacteria in the colon is independent of Myd88 signals,
however the carriage of bacteria to the MLN was induced
by the presence of the microbiota7,24,30 Migration of leu-
kocytes to and from LNs is dependent on sphingosine
1 phosphate gradients and inactivation of the sphingosine
Figure 5. Dissemination of translocated bacteria and induction of T cell responses in the LN draining the proximal colon following antibiotic
therapy are dependent upon S1PR. (A) Graphical representation of CFUs per colon draining MLN in mice following antibiotic treatment
and i.p. injection with 5 mg/kg FTY72040 or 20 mg/kg SEW287143 48 hours before MLN harvest. (B-F) Mice were given normal drinking
water (Control; Con) or antibiotic treatment (ABX), i.v. injected with 4.2£ 106 CFSE labeled ovalbumin (Ova) speciﬁc CD4C splenic T cells
from OTII T cell receptor transgenic mice, and 24 hours later given 50 mg Ova via enema and i.p. injection of vehicle or 5 mg/kg FTY720.
Three days following ovalbumin administration, colon draining LN homogenates were analyzed by ﬂow cytometry for CFSE dilution. (B)
Representation ﬂow plot of colonic draining MLN, colic LN, and caudal and iliac LN in mice not receiving antibiotics (Control). (C) Graph-
ical representation of percent of OTII cells from the various LN and treatments that had diluted CFSE past the initial ﬂuorescent intensity.
(D-F) Representation ﬂow plot of (D) colonic draining MLN, (E) colic LN, and (F) caudal and iliac LN in control mice and mice following
antibiotic treatment with or without FTY720 injection. n D 2 or 3 mice per group, ND D not detected.
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1 phosphate receptor (S1PR) inhibits circulation of lym-
phocytes.36 Intestinal APCs express the S1PR,37 and inhi-
bition of S1PR in clinical trials is an effective treatment of
IBD and colitis,38,39 though the mechanism of action is
incompletely understood. Additionally, it has been shown
CX3CR1CMNPs require S1PR expression for trafﬁcking
of cells carrying pathogenic bacteria to secondary LNs in
a model of Yersinia infection.40 Pan S1PR inactivation
with FTY720 or selective S1PR1 inactivation with
SEW2871 inhibited bacterial translocation to the colon
draining MLN (Fig. 5A), suggesting that S1PR blockade
might prevent inﬂammatory responses in theMLN.
Antibiotic therapy induces T cell responses to
luminal antigens in the colon draining LN
We previously observed that following antibiotic ther-
apy, inﬂammatory cytokine responses were seen in
the colon draining MLN. These inﬂammatory
responses could be due to innate immune responses
to bacteria and bacterial products as well as T cell
responses to luminal antigens delivered by colonic
GAPs. We evaluated the ability to induce antigen spe-
ciﬁc immune responses in the colon draining LNs fol-
lowing antibiotic therapy. In the absence of antibiotic
therapy, little to no antigen speciﬁc T cell proliferation
in response to luminal antigen was observed in LN
draining the cecum, ascending colon (colonic MLN)
and transverse colon (colic LN), while proliferation
was observed in the LNs draining the descending
colon and sigmoid colon (caudal and iliac LN;
Fig. 5B), correlating with presence of GAPs in the
descending colon and sigmoid colon and their absence
in proximal regions of the colon in the steady-state
(Fig. 1A, C, D and E). This also is consistent with
GAPs as a mechanism delivering antigen to the caudal
and iliac LNs to induce tolerance to rectally adminis-
tered antigens.18 In contrast, following antibiotic ther-
apy, robust T cell proliferation to luminal antigen was
observed in the LNs draining all segments of the colon
(Fig. 5C-F), correlating with the presence of GAPs in
all segments of the colon after antibiotic treatment
(Fig. 1A, C, D and E). This suggests that the inﬂam-
matory cytokines we observed to be produced in the
colon draining LN7 may inﬂuence na€ıve T cell differ-
entiation to promote inﬂammatory responses to oth-
erwise harmless luminal antigens encountered in the
setting of bacterial translocation following antibiotic
therapy.
Treatment with FTY720 to inhibit S1PR depen-
dent migration at the time of the luminal OVA
administration almost completely abrogated antigen
speciﬁc T cell proliferation in the LNs draining the
cecum, ascending colon and transverse colon
(colonic MLN and colic LN), while only modestly
affecting antigen speciﬁc T cell proliferation in the
LNs draining the descending colon and sigmoid
colon (caudal and iliac LN), which resembled pro-
liferation to luminal antigen untreated mice
(Fig. 5C-F). This suggests that the colonic LP-
MNPs acquiring luminal antigen and inducing
robust T cell responses in the MLNs following anti-
biotic therapy require S1PR to migrate to the MLN.
This also suggests that a second LP-MNP popula-
tion may acquire luminal antigens in the distal
colon and carry them to the LN to induce more
moderate proliferative responses in an S1PR inde-
pendent manner in the absence of antibiotic ther-
apy. Our observations might also indicate that the
beneﬁcial effect S1PR inhibitors have on colitis are
in part due to inhibition of LP-MNP trafﬁcking to
the LN and subsequent inhibition of T cell
responses.
Conclusion
The translocation of bacteria across the intestinal epi-
thelium following antibiotic treatment is a well recog-
nized and, until now, enigmatic process. Here we
show a window of time following antibiotics where
the colonic microbiota is permissive to the formation
of colonic GAPs. Once formed, colonic GAPs can
deliver a variety of substances, including protein anti-
gens and live commensal bacteria. CD103C and
CX3CR1C LP-MNPs interact with GAPs to access
luminal antigen, while commensal bacteria are pri-
marily acquired by CX3CR1C LP-MNPs.7 After
acquiring commensal bacteria and luminal antigens
LP-MNPs trafﬁc to the draining LNs promoting an
inﬂammatory environment, which could result in
inﬂammatory T cell responses to otherwise innocuous
antigens. It is not known if inﬂammatory responses
are induced in the LN draining the distal colonic seg-
ments following antibiotic therapy, which may be an
exception to this sequence of events, as the distal
colon GAPs are present in the steady-state and bacte-
rial translocation to the LNs draining the distal colon
was not observed in the steady-state or following
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antibiotic treatment. Alterations in the gut microbiota
and antibiotic use are increasingly being associated
with inﬂammatory disorders. The observations pre-
sented here demonstrate that inﬂammatory responses
following antibiotic use occur in part due to translo-
cation of gut bacteria via GAPs and suggest that
strategies such as manipulation of the gut microbiota
following antibiotic therapy to prevent translocation
or blockade of LP-MNP trafﬁcking to prevent bacte-
rial dissemination may be approaches to mitigate
antibiotic associated inﬂammatory responses.
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